GB371550A - Process for purifying physiologically active substances - Google Patents

Process for purifying physiologically active substances

Info

Publication number
GB371550A
GB371550A GB8028/31A GB802831A GB371550A GB 371550 A GB371550 A GB 371550A GB 8028/31 A GB8028/31 A GB 8028/31A GB 802831 A GB802831 A GB 802831A GB 371550 A GB371550 A GB 371550A
Authority
GB
United Kingdom
Prior art keywords
product
precipitate
per cent
precipitated
treated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB8028/31A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IG Farbenindustrie AG
Original Assignee
IG Farbenindustrie AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IG Farbenindustrie AG filed Critical IG Farbenindustrie AG
Publication of GB371550A publication Critical patent/GB371550A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Removal Of Specific Substances (AREA)

Abstract

Crude extracts containing cardiac substances are purified by precipitating the active substances with heavy metal compounds such as copper, silver, lead or mercury salts, with or without the addition of other salts such as sodium acetate or magnesium salts, and subsequently removing the precipitant. Examples of the invention are as follows: (1) the mother liquor, remaining after the precipitation of blood-sugar level reducing substances with ammonium sulphate from pancreas extract, is mixed with acetone; 500 c.c. of the aqueous layer which forms is diluted to 2 litres, 100 gms. of sodium acetate and 160 c.c. of 40 per cent sodium bisulphite solution added and the mixture boiled; 10 per cent copper sulphate is then added until no more precipitate forms; the liquid is boiled for three minutes, filtered hot, the precipitate suspended in water, slightly acidified and the copper precipitated with hydrogen sulphide; the filtered solution is evaporated in vacuo and the residue dissolved in water, neutralized and standardized: (2) organic phosphorus-containing substances are removed from the product of (1) by precipitation with magnesia mixture, and the filtrate is treated with excess magnesia mixture and ammoniacal silver nitrate; the precipitate is separated, washed with ammonia, suspended in water, and the silver precipitated with hydrochloric acid; the precipitate is filtered off and the filtrate evaporated in vacuo and redissolved: (3) a mother liquor as in (1) is diluted, precipitated with 10 per cent copper sulphate solution in the presence of sodium acetate and sodium bisulphite, and worked up as in (1): (4) the product of the example of Specification 279,445, [Class 81 (i), Disinfecting &c.], is precipitated with 80 per cent copper sulphate solution in the presence of sodium acetate and sodium bisulphite and further worked up as in (1): (5) the product of example (1) of Specification 335,202, [Class 81 (i), Disinfecting &c.], is treated as in (2) : (6) the product of the process of Specification 359,523 is treated as in (1) : (7) the product of example (1) is treated with solid cuprous chloride while boiling and further worked up as in (1) : (8) the product of the example of Specification 279,445 is rendered slightly ammoniacal and precipitated with 25 per cent lead acetate solution, filtered, and the lead removed from the precipitate, ground in water, by treatment with 20 per cent sulphuric acid; traces of lead are removed from the filtrate with hydrogen sulphide: (9) the product of example (1) of Specification 335,202 is treated with mercuric chloride solution and the mercury removed from the precipitate with hydrogen sulphide. Specifications 306,606 and 306,608, [both in Class 81 (i), Disinfecting &c.], also are referred to.
GB8028/31A 1930-03-14 1931-03-16 Process for purifying physiologically active substances Expired GB371550A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE371550X 1930-03-14

Publications (1)

Publication Number Publication Date
GB371550A true GB371550A (en) 1932-04-28

Family

ID=6327171

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8028/31A Expired GB371550A (en) 1930-03-14 1931-03-16 Process for purifying physiologically active substances

Country Status (1)

Country Link
GB (1) GB371550A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2789983A (en) * 1954-08-03 1957-04-23 Commercial Solvents Corp Recovery of cycloserine

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2789983A (en) * 1954-08-03 1957-04-23 Commercial Solvents Corp Recovery of cycloserine

Similar Documents

Publication Publication Date Title
US2998450A (en) Process of preparing nu-acetyl-p-amino phenol
Smith et al. Studies on the Polymethylbenzenes. XIII. 1 Mercuration
GB371550A (en) Process for purifying physiologically active substances
US2046937A (en) Process for the preparation of copper compounds from metallic copper
US2302204A (en) Process for the manufacture and purification of uric acid
DE616987C (en)
GB579459A (en) Process for the purification of 4-hydroxycoumarins
Ewins Note on the Isolation of Methylguanidine by the Silver Method
US1669328A (en) Specific antidiabetic principle
DE868908C (en) Process for the production of dithiooxamide (rubean hydrogen)
DE909936C (en) Process for the extraction of active ingredients from flowers of Arnica montana
US2361576A (en) Method of refining a crude 1-naphthylacetic acid
US1924073A (en) Stable ammonium salt of primula saponine
US1890373A (en) Hormone and the process of obtaining same
US2631147A (en) Preparation of medicinal grade sulfamethazine
US1798030A (en) Method for reducing nitroarylarsonic acids
DE668576C (en) Process for the separation and purification of glutathione from aqueous solutions
AT132842B (en) Process for the production of cardiac agents in purified form.
DE733809C (en) Process for the extraction of glycosides from Strophanthus Kombe
DE325957C (en) Process for the production of a copper-tannin-protein compound
GB1214093A (en) Purification of deoxycholic acid
DE854957C (en) Process for the production of amines
GB497081A (en) Improvements in obtaining the antineuritic vitamin
SU67225A1 (en) Method of cleaning technical uric acid
DE670098C (en) Process for the enrichment of biotin